Correlation Between Bioatla and Iteos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bioatla and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioatla and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioatla and Iteos Therapeutics, you can compare the effects of market volatilities on Bioatla and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioatla with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioatla and Iteos Therapeutics.

Diversification Opportunities for Bioatla and Iteos Therapeutics

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Bioatla and Iteos is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Bioatla and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Bioatla is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioatla are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Bioatla i.e., Bioatla and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between Bioatla and Iteos Therapeutics

Given the investment horizon of 90 days Bioatla is expected to under-perform the Iteos Therapeutics. In addition to that, Bioatla is 2.76 times more volatile than Iteos Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Iteos Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest  858.00  in Iteos Therapeutics on August 30, 2024 and sell it today you would lose (4.00) from holding Iteos Therapeutics or give up 0.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bioatla  vs.  Iteos Therapeutics

 Performance 
       Timeline  
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bioatla is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Iteos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bioatla and Iteos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bioatla and Iteos Therapeutics

The main advantage of trading using opposite Bioatla and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioatla position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.
The idea behind Bioatla and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format